Cocrystal Pharma, Inc.COCPNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank14
Studio
Year-over-Year Change

Return on equity

Latest
-183.81%
↓ 145% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-75.12%
Historical baseline
PeriodValueYoY Change
2024-183.81%-169.7%
2023-68.16%+30.6%
2022-98.16%-436.6%
2021-18.29%+0.5%
2020-18.38%+90.2%
2019-187.37%-155.5%
2018-73.33%-12508.2%
2017-0.58%+99.2%
2016-73.18%-144.7%
2015-29.91%-